Opipramol Heumann (Opipramol Hydrochloride)

Opipramol Hydrochloride, the active ingredient in Opipramol Heumann, is a tricyclic antidepressant presented as an oral tablet for oral use. It treats generalized anxiety disorder, other anxiety conditions, and depressive disorders in adult patients.

GNH USA supplies Opipramol Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Opipramol Hydrochloride is used in the management of anxiety‑related and depressive disorders.

- Generalized anxiety disorder: reduces excessive worry and tension. - Anxiety: alleviates persistent nervousness and physical symptoms of anxiety. - Depressive disorders: improves mood and alleviates depressive symptoms.

Adverse reactions may occur with Opipramol Hydrochloride and should be monitored.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to discomfort. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Hepatic injury: signs of liver dysfunction such as jaundice. - Cardiac arrhythmia: irregular heart rhythm that may require medical attention.

Before initiating therapy, clinicians should consider several safety measures.

- Hepatic function assessment: evaluate liver enzymes prior to use. - Sedation monitoring: advise patients about potential drowsiness, especially when driving. - Gradual discontinuation: taper the dose to avoid withdrawal symptoms. - Elderly caution: start with lower doses and monitor for orthostatic hypotension. - Alcohol avoidance: limit intake as it may increase sedation. - Store below 25°C: keep in the original pack, protect from moisture.

Opipramol Hydrochloride can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Central nervous system depressants: enhanced sedation and respiratory depression. - Anticholinergic agents: increased risk of severe dry mouth and constipation.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): potential for serotonin syndrome. - Antihistamines: additive drowsiness. - Alcohol: may potentiate central effects and impair cognition.